ATE224403T1 - Verwendung von kaseinfragmenten als wachstumerförderer - Google Patents

Verwendung von kaseinfragmenten als wachstumerförderer

Info

Publication number
ATE224403T1
ATE224403T1 AT96935129T AT96935129T ATE224403T1 AT E224403 T1 ATE224403 T1 AT E224403T1 AT 96935129 T AT96935129 T AT 96935129T AT 96935129 T AT96935129 T AT 96935129T AT E224403 T1 ATE224403 T1 AT E224403T1
Authority
AT
Austria
Prior art keywords
growth promoters
casein
casein fragments
disclosed
alpha
Prior art date
Application number
AT96935129T
Other languages
English (en)
Inventor
John Arthur Smith
Mark Charles Wilkinson
Qing-Ming Liu
Original Assignee
Pepsyn Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pepsyn Ltd filed Critical Pepsyn Ltd
Application granted granted Critical
Publication of ATE224403T1 publication Critical patent/ATE224403T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Processing Of Meat And Fish (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Crushing And Pulverization Processes (AREA)
  • Bipolar Transistors (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT96935129T 1995-10-31 1996-10-31 Verwendung von kaseinfragmenten als wachstumerförderer ATE224403T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9522302.0A GB9522302D0 (en) 1995-10-31 1995-10-31 Growth promoters
PCT/GB1996/002658 WO1997016460A1 (en) 1995-10-31 1996-10-31 Casein fragments having growth promoting activity

Publications (1)

Publication Number Publication Date
ATE224403T1 true ATE224403T1 (de) 2002-10-15

Family

ID=10783173

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96935129T ATE224403T1 (de) 1995-10-31 1996-10-31 Verwendung von kaseinfragmenten als wachstumerförderer

Country Status (6)

Country Link
EP (1) EP0861265B1 (de)
JP (1) JPH11515022A (de)
AT (1) ATE224403T1 (de)
DE (1) DE69623803T2 (de)
GB (1) GB9522302D0 (de)
WO (1) WO1997016460A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1114060B1 (de) * 1998-09-15 2003-06-11 NIZO food research Verfahren zur herstellung von peptiden aus biologischen flüssigkeiten und nach diesem verfahren herstellbare peptide
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
GB0016189D0 (en) * 2000-06-30 2000-08-23 Pepsyn Ltd Cosmetic composition
GB0209384D0 (en) * 2002-04-24 2002-06-05 Pepsyn Ltd Peptide composition
JP2012152138A (ja) * 2011-01-26 2012-08-16 Biolink Hanbai Co Ltd 食品組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03255095A (ja) * 1990-03-02 1991-11-13 Kanebo Ltd カゼインペプチド
EP0457565B1 (de) * 1990-05-18 1997-07-30 Morinaga Milk Industry Co., Ltd. Milchproteinhydrolysate und Zusammensetzungen zur Verwendung als Haar- und Hautbehandlungsmittel
JPH06211689A (ja) * 1993-01-19 1994-08-02 Kanebo Ltd 鎮静剤及び精神安定用食品

Also Published As

Publication number Publication date
GB9522302D0 (en) 1996-01-03
EP0861265A1 (de) 1998-09-02
EP0861265B1 (de) 2002-09-18
WO1997016460A1 (en) 1997-05-09
JPH11515022A (ja) 1999-12-21
DE69623803D1 (de) 2002-10-24
DE69623803T2 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
HU902697D0 (en) Process for the enzymatic removal of the n-terminal sequence of proteins
ATE171192T1 (de) Peptide und proteine, verfahren zur ihren herstellung und die verwendung als cholesterol- annehmer
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
CA2032153A1 (fr) Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
CA2189657A1 (fr) Fractions polypeptidiques solubles de la proteine lag-3; procede de production; composition therapeutique; anticorps anti-idiotype
NZ232742A (en) Yeast heterologous protein production method, vectors, dna constructs and proteins so produced and aprotinin (1-58) so produced
EP2327775A3 (de) Herstellung von menschlichen alpha-Galactosidase A
AU4415796A (en) Production of c-terminal amidated peptides from recombinant protein constructs
AU1003888A (en) Pancreatic secretory trypsin inhibitor and variants thereof produced by a recombinant host, process, expression vector and recombinant host therefore and pharmaceutical use thereof
CA2249180A1 (en) Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
DE69840024D1 (de) Antimikrobielle Peptide, abstammend von Ubiquicidin
ES2009588A6 (es) Un metodo para la preparacion de un polipeptido.
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
FI964186A0 (fi) Ei-liittävät gp350/220-variantit
WO1999002708A8 (en) Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein
DE69227517D1 (de) Produktion von peptid-amiden
AU1444699A (en) Single-chain polypeptides comprising troponin i and troponin
EP0238275A3 (en) Recombinant product
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
CA2259640A1 (en) Human glycine transporter
ATE282088T1 (de) Aminopeptidase, welche von bacillus licheniformis abstammt und verfahren zur herstellung von proteinen des natürlichen typs
AU1454495A (en) Recombinant production of modified proteins lacking certain amino acids
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties